AXGN Stock Summary and Trading Ideas (Axogen | NASDAQ:AXGN)

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Axogen trades on the NASDAQ stock market under the symbol AXGN.

As of April 22, 2024, AXGN stock price climbed to $6.86 with 175,170 million shares trading.

AXGN has a beta of 1.73, meaning it tends to be more sensitive to market movements. AXGN has a correlation of 0.09 to the broad based SPY ETF.

AXGN has a market cap of $296.39 million. This is considered a Small Cap stock.

In the last 3 years, AXGN stock traded as high as $23.94 and as low as $3.45.

The top ETF exchange traded funds that AXGN belongs to (by Net Assets): VTI, IWM, VXF, IWO, IHI.

AXGN has underperformed the market in the last year with a price return of -32.1% while the SPY ETF gained +22.3%. AXGN has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -21.9% and -12.1%, respectively, while the SPY returned +3.9% and -3.6%, respectively.

AXGN support price is $6.28 and resistance is $6.72 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AXGN stock will trade within this expected range on the day.